22 mar: Forny med træ
25 mar: Designnyt fra Århus
24-03-2010 16:18:00

Tech Firms Can Now Check the Pulse of Their Current Business Health with Free Zurich Enterprise Risk Management HealthCheck Tool

Relateret indhold
31 jan - 
Tirsdagens aktier: Chr H i top, mens Novo og Genmab ble..
31 jan - 
Tirsdagens aktier: Chr H i top, mens Novo og Genmab for..
31 jan - 
Aktier/middag: Med Chr. Hansen, Mærsk og Europa i plus
Relateret debat
19 apr - 
Det er noget ævl du ikke har fået gode råd se fx mit sv..
19 apr - 
Ja, via samarbejde med et seriøst site jeg ikke lige ka..
17 apr - 
Er det virkelig sådan i ønske nye i forummet skal behan..

Zurich, a leading property & casualty insurance provider to technology

companies in North America1, announced today the launch of

Zurich Enterprise Risk Management (ERM) HealthCheck Tool. This new,

easy-to-use tool helps provide mid-size to large technology companies

with a realistic check of their current ERM preparedness. ERM promotes a

holistic, 360-degree approach to risk and opportunity management. It can

help to uncover and manage a company’s business challenges, including

operations and procedures, management styles and business strategies,

industry issues, emerging risks and more.

“Technology firms, by their nature, are particularly susceptible to a

variety of emerging, ever-changing risks that can, if not anticipated

and managed, jeopardize their profitability, or even their very

existence,” said David Allred, technology practice leader for Zurich

North America Commercial. “For example, many firms have complex global

supply chains that are susceptible to a variety of interruptions. ERM

can also look at things like labor relations or the ability to keep

research and development (R & D) efforts functioning in the event of a

physical loss at their facilities. With an effective ERM program in

place, technology firms will be better prepared to manage the risks and

challenges to profitability to enable improved strategic decision

making.”

Not only does the Zurich ERM HealthCheck Tool offer a high-level

assessment of a technology firm’s current ERM strategy and processes, it

also provides the user with some recommendations on how to improve

his/her businesses’ current ERM preparedness. This tool takes a broad

look at ERM, the commitments involved in implementing it effectively,

and the benefits that businesses can achieve as a result.

According to Linda Conrad, director of Strategic Business Risk for

Zurich Services Corporation, a well-developed ERM infrastructure can be

a real competitive advantage. Conrad said, "The objective of ERM is to

manage business resilience by 'putting your money where your risk is' so

companies can better leverage strategic business growth opportunities."

ERM can help businesses,

  • Protect tangible and intangible assets;

  • Minimize total cost of risk and barriers to achieving business

    objectives;

  • Maintain creditworthiness;

  • Maximize strategic growth opportunities;

  • Provide management assurance to regulators and stakeholders, and

  • Limit damage to their reputation.

To take the free assessment, go to https://www.zurichnac.com/technology-ERM.

About Zurich

Zurich in North America is a part of Zurich Financial Services Group

(Zurich), an insurance-based financial services provider with a global

network of subsidiaries and offices in North America and Europe as well

as in Asia Pacific, Latin America and other markets. Founded in 1872,

the Group is headquartered in Zurich, Switzerland and employs

approximately 60,000 people serving customers in more than 170

countries, including more than 9,500 employees in North America.

Zurich was the first overseas insurer to enter the U.S. market in 1912.

According to Highline Data LLC (NAIC 2008), Zurich in North America (www.zurichna.com)

is the second-largest writer of commercial general liability insurance

and the fourth-largest commercial property-casualty insurance company,

serving the global corporate, large corporate, middle market,

specialties and programs sectors. Zurich’s risk engineering services in

the United States are provided by Zurich Services Corporation.

1 Zurich insures 37 of the 44 technology companies in the

2009 Fortune 500.

Media contact:

Jennifer Nowacki

Zurich

(847)

605-6511

jennifer.nowacki@zurichna.com

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
19 apr
EI
Ja, via samarbejde med et seriøst site jeg ikke lige kan huske hvad hedder, som lukkede ned og isted..
2

Vestas vil til tops i Indien - citat

25-04-2017 15:02:38
Tirsdag blev Vestas' seneste 2 megawatts-vindmølle lanceret i New Delhi, og Clive Turton, der er chef for Vestas' Asien-afdeling slog fast, at den danske vindmølleproducent vil være førende i Indien.- Inden er det mest vigtige og afgørende marked i Asien-Stillehavet-regionen. Vi mener, vi har den bedste teknologi, og nu kan Vestas komme på førstepladsen her i landet, sagde Clive Turton til branche..

Novo: Amerikansk rival har stærkt diabetessalg i første kvartal

25-04-2017 12:33:38
En af Novo Nordisks største konkurrenter - det amerikanske medicinalselskab Eli Lilly - solgte mere diabetesmedicin i første kvartal end ventet af analytikerne. Også indtjeningen overrasker til den positive side.Eli Lilly kom ud af kvartalet med et nettooverskud på 1040 mio. dollar mod 882 mio. dollar i samme periode sidste år. Det justerede resultat per aktie landede på 0,98 dollar, hvilket var e..

Aktier/åbning: C20 Cap fortsætter kursen mod rekord

25-04-2017 09:26:57
Der er tirsdag morgen stadig en smule brændstof tilbage i det franske valgresultat til nye stigninger på aktiemarkederne.Ingen af de danske eliteaktier gør dog særligt væsen af sig, og man skal ud blandt sidepapirerne for at finde større bevægelser til blandt andet FLSmidth og Össur. FLS-aktien stiger efter godt nyt fra en konkurrent, mens Össur er i modvind oven på en sænket anbefaling fra Nordea..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vestas-rival risikerer farvel til børsen efter nyt milliardunderskud
2
Aktier/tendens: Bankerne i fokus på ny plusdag
3
Genmabs Arzerra-partner rammer over forventningerne
4
Novo: Amerikansk rival har stærkt diabetessalg i første kvartal
5
Vestas vil til tops i Indien - citat

Relaterede aktiekurser

Euroinvestor.com A/S 10,80 0,0% Aktiekurs uændret
Zurich Insurance N 273,00 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
26. april 2017 06:12:16
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20170403.1 - EUROWEB6 - 2017-04-26 06:12:16 - 2017-04-26 06:12:16 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x